NHS FPX 6004 Assessment 1 Dashboard Metrics, Benchmarks, and Policy Decisions
Student name
6004 A1
Capella University
Professor Name
Submission Date
Dashboard Metrics, Benchmarks, and Policy Decisions
Most health care companies use performance displays to monitor their adherence to quality standards mandated by the federal government. The Hospital-Acquired Condition Reduction program was developed by CMS (Centers for Medicare and Medicaid Services) to help reduce the prevalence of avoidable harm to patients (CMS, 2026). Tracking CLABSIs (central line-associated bloodstream infections) continues to be one of the key indicators in this value-based purchasing program. A performance display system promotes quality improvement at the team level and helps in the identification of performance gaps.
Policy Compliance with Healthcare Law
Section 1886(p) of the Social Security Act established the Hospital-Acquired Condition (HAC) Reduction Program. The HAC Reduction Program is applicable to all general acute care hospitals impacted by CMS (2026). The affected law states that hospitals in the lowest quartile will face an automatic 1% reduction in their Medicare reimbursement (CMS, 2026). Per the Joint Commission infection prevention and control chapter, effective July 1, 2024, hospitals will be required to implement evidence-based infection prevention strategies as per the CDC guidelines (The Joint Commission, 2024). To ensure compliance with the CMS mandate and the Joint Commission standard, hospitals are required to develop infection control strategies at the organizational level to fulfill the regulatory mandates of both the Agency and the accreditation body. Should the hospital be challenged legally or by an accreditation body in an instance where there is believed to be a lack of compliance, it is likely the hospital will be required to demonstrate compliance with infection control strategies.
Inadequate hand hygiene monitoring or failure to implement CLABSI bundle provisions in hospital IC policies poses a risk as it violates federal and accreditation standards. As part of the National Patient Safety Goal (NPSG) 07.01.01, The Joint Commission requires that hospitals define their own set of hand hygiene protocols and compliance criteria based on CDC or WHO guidelines (The Joint Commission, 2024). Additionally, CMS mandates that all hospitals report HAI data to the CDC’s National Healthcare Safety Network (NHSN) as part of their quality reporting obligation (CMS, 2026). A lack of compliance in any of the stated areas constitutes a Patient Safety concern and a regulatory disparity for the Entity.
Benchmarks Associated with Healthcare Law
To establish measurable criteria for the CLABSI (central line-associated bloodstream infection) rate, the CDC, as the primary national benchmark, relies on the Standardized Infection Ratio (SIR) in the NHSN (National Healthcare Safety Network) (CDC 2026). The SIR is calculated for each healthcare facility by the CDC and represents the infections that the facility reported to NHSN and the predicted infections that the facility would have had based on the 2015 national baseline data (CDC 2024). In general, a facility is considered to be performing satisfactorily if it has an SIR of less than 1.0, and if the SIR is greater than 1.0, the facility is considered to be performing unsatisfactorily and is required to undertake improvement measures.
Connection Between Benchmarks and Policy
The calculation for the Total HAC Score for hospitals that is performed by the Centers for Medicare and Medicaid Services (CMS) is based on the NHSN-reported SIR data and is done by considering the benchmark Performance for all hospitals. A hospital placed in the lowest quartile of Total HAC scores can expect a one percent decrease in its Medicare funding for the year (CMS, 2026). The effect of a hospital’s performance against the benchmarks illustrates the dependence of measurement on policy and the Federal Quality Framework for the provision of Health Care Services.
Consequences of Not Meeting Benchmarks
Falling short of CLABSI benchmarks can have major financial, legal, and public relations implications for an organization. A one percent reduction in the Medicare Fee for Service discharges is the result of a Total HAC score that places a hospital in the top 75 percent of hospitals (CMS 2026). Payment reductions for Hospital Acquired Infections result in a savings of approximately 350 million dollars per year for the Medicare program as a result of these payment reductions (Wolters Kluwer 2020). Failure to effectively engage with the infection prevention data can not only harm the patients, but also result in significant losses to the organization.
Implications for Healthcare Organizations
The rise of benchmark non-conformance for CLABSI rates reveals a deeper, underlying problem within the inter-professional care team. Published scores for Hospital-Acquired Conditions (HAC) can damage an institution’s reputation, erode patient trust, and harm the institution’s ability to negotiate with payers (Chen et al., 2022). As part of the HAC Reduction Program, 724 hospitals were penalized with payment reductions from Medicare for Fiscal Year 2025 (Chief Healthcare Executive, 2025). The HAC score penalties impact not only the fiscal resources of hospitals, but also the staffing of nurses and infection prevention specialists, and the allocation of resources for quality improvement and infection prevention.
Assumptions Underlying the Analysis
The assumption is that National Healthcare Safety Network (NHSN) reported CLABSI data accurately reflect the CLABSI infection rates at hospitals reporting to the NHSN. The CDC National Center for Emerging and Zoonotic Infectious Diseases uses risk-adjusted data for 2015 as a reference to establish the Standardized Infection Ratio (SIR) (CDC, 2024). The assumption is that hospitals enter data in the same manner; however, in general, states with stricter data validation report higher SIRs due to better detection (CDC, 2026). These assumptions should be considered when evaluating the performance disparity of individual facilities compared to national benchmarks.
Evaluation of Benchmark Underperformance
Most acute care hospitals in the U.S. still struggle with CLABSI infection cases despite some progress. From 2023-2024, the reported cases of CLABSI infections at U.S. acute care hospitals dropped by 9% (Centers for Disease Control and Prevention, 2026). In one state, the reported SIR for CLABSI cases in acute care hospitals was below the national 2015 standard of 1.0 (Centers for Disease Control and Prevention, 2026). The ongoing benchmark underperformance in specific regions and locations further justifies the need for directed and purposeful interprofessional quality improvement CLABSI elimination efforts.
It is essential for interprofessional team members to include CLABSI infection case nurses, physicians, infection preventionists, and quality officers in the efforts to address the persistent causes of CLABSI. The available CLABSI data managed by the HAC Reduction Program is making it possible for patients, competitors, and the press to notice poor HAC performance by an institution (Chief Healthcare Executive, 2025). An institution that considers HAC performance to be an isolated performance metric fails to take advantage of a vital opportunity to identify and enhance the entire performance of the organization (Kumar & Gutierrez, 2025). All organizations must develop a robust cross-functional plan of action that combines clinical and financial leadership to ensure the capacity to achieve ongoing, sustained improvement related to established performance benchmarks.
Potential Impact on Quality and Performance
Improving the CLABSI SIR performance will greatly improve patient safety and the organization’s quality outcomes. The National Action Plan 2024–2028 aims to reduce CLABSIs by 40% from the 2022 baseline. Achieving this goal will reduce the number of patients impacted by preventable harm and will positively impact the organization’s bottom line by eliminating cost-shifting and budget reductions as a result of CLABSIs. The Centers for Medicare and Medicaid Services will impose more stringent penalties on health care organizations that do not demonstrate improvement in CLABSI prevention. The commitment to an organizational culture of continual improvement regarding benchmark performance illustrates the organization’s commitment to safe, accountable practices that benefit patients and staff.
Advocating Ethical and Sustainable Actions
Achieving CLABSI prevention will require the use of ethical actions adhering to the four principles of nursing ethics. The principle of beneficence states that, in order to prevent harm to patients, the healthcare team is required to implement evidence-based CLABSI prevention bundles. The principle of non-maleficence is upheld by nursing staff when they fulfill their duty to prevent CLABSI through compliance with care and insertion guidelines. The principle of justice is upheld by providing equitable care and protection from CLABSI to patients of all races, nationalities, and social classes. The CLABSI prevention bundle is completed through the principle of autonomy by promoting the active participation of patients and their families in CLABSI prevention education.
Hospital leadership and staff, along with infection preventionists and quality improvement teams, must collaborate to develop and implement the CLABSI prevention strategies. Some of the strategies that have the potential to be sustainable are conducting hand hygiene compliance audits, providing inter-professional education, and CLABSI bundle checklist standardization at all operating units (Aalalhareth & Abdullah, 2024). According to the Chief Healthcare Executive (2025), the CMS data support that hospitals that do not comply with the infection measures will suffer fallout from negative publicity that will diminish the patients’ trust in the hospital and the hospital’s reputation. Being ethical leaders, it requires a sustained commitment to providing all staff with culturally and clinically appropriate education. Ethical leaders also must provide policy protections that ensure all at-risk and diverse populations receive safety measures with equal protection.
Conclusion
Infection control policies are essential for all healthcare systems for compliance with federal regulations, the Joint Commission, and CDC, for the safety of clientele and the financial bottom line. Hospitals will be evaluated based on the CLABSI SIR Data and will be expected to show advancement in this area. Some of the national success examples of this program state a 9 percent reduction in CLABSI for the years 2024-2026. Not all hospitals have accomplished the necessary steps to meet this goal. Continuous collaboration of interprofessional healthcare teams and ethical leadership, along with quality improvement initiatives, will provide the success needed for benchmark compliance.
References
Aalalhareth, M., & Abdullah, M. (2024). Optimizing infection control through interprofessional collaboration: An integrative review of roles, responsibilities, and evidence across all healthcare departments. The Review of Diabetic Studies, 153–165. https://doi.org/10.70082/7e330c13
Centers for Disease Control and Prevention. (2024). The NHSN standardized infection ratio (SIR): A guide to the SIR (based on 2015 national baseline, updated March 2024). https://www.cdc.gov/nhsn/pdfs/ps-analysis-resources/nhsn-sir-guide.pdf
Centers for Disease Control and Prevention. (2026). 2024 national and state healthcare-associated infections progress report. https://www.cdc.gov/healthcare-associated-infections/php/data/progress-report.html
Centers for Medicare & Medicaid Services. (2026). Hospital-acquired condition reduction program. https://www.cms.gov/medicare/quality/value-based-programs/hospital-acquired-conditions
Chen, H.-C., Cates, T., & Taylor, M. (2022). The effect of patient quality measurements and HCAHPS patient satisfaction on hospital reimbursements. Human Systems Management, 42(4), 1–15. https://doi.org/10.3233/hsm-220042
Chief Healthcare Executive. (2025). Why the CMS hospital infection program must be on every C-suite radar. https://www.chiefhealthcareexecutive.com/view/why-the-cms-hospital-infection-program-must-be-on-every-c-suite-radar
Konstantopoulos, W., Collins, K., Diaz, R., Duber, H., Edwards, C., Hsu, A., Ranney, M., Riviello, R., Wettstein, Z., & Sachs, C. (2023). Race, healthcare, and health disparities: A critical review and recommendations for advancing health equity. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health, 24(5), 906–918. https://doi.org/10.5811/westjem.58408
Kumar, A., & Gutierrez, J. A. (2025). Impact of machine learning on intrusion detection systems for the protection of critical infrastructure. Information, 16(7), e515. https://doi.org/10.3390/info16070515
The Joint Commission. (2024). R3 report issue 41: New and revised requirements for infection prevention and control for critical access hospitals and hospitals. https://www.jointcommission.org/standards/r3-report/r3-report-issue-41-new-and-revised-requirements-for-infection-prevention-and-control-for/
U.S. Department of Health & Human Services. (2025). National HAI targets & metrics. https://www.hhs.gov/oidp/topics/health-care-associated-infections/targets-metrics/index.html
Wolters Kluwer. (2020). Hospital-acquired infections and CMS reimbursement: Implications for hospitals. https://www.wolterskluwer.com/en/expert-insights/hospitalacquired-infections-and-cms-reimbursement-implications-for-hospitals
